The changing face of corporate venturing in biotechnology

被引：9

作者：

von Krogh, Georg ^{[1
]}

Battistini, Boris ^{[1
]}

Pachidou, Fotini ^{[1
]}

Baschera, Pius ^{[1
]}

机构：

[1] ETH, Dept Management Technol & Econ, Zurich, Switzerland

来源：

NATURE BIOTECHNOLOGY | 2012年 / 30卷 / 10期

关键词：

D O I：

10.1038/nbt.2383

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

页码：911 / 915

页数：5

共 13 条

[1] Towards understanding who makes corporate venture capital investments and why [J].

Basu, Sandip ;

Phelps, Corey ;

Kotha, Suresh .

JOURNAL OF BUSINESS VENTURING, 2011, 26 (02) :153-171

[2] In defense of life sciences venture investing [J].

Booth, Bruce L. ;

Salehizadeh, Bijan .

NATURE BIOTECHNOLOGY, 2011, 29 (07) :579-583

[3] Beyond the biotech IPO: a brave new world [J].

Booth, Bruce L. .

NATURE BIOTECHNOLOGY, 2009, 27 (08) :705-709

[4]

Dushnitsky G., 2011, Business Strategy Review, V22, P44, DOI [DOI 10.1111/J.1467-8616.2011.00773.X, 10.1111/j.1467-8616.2011.00773.x]

[5] ENTREPRENEURIAL FINANCE MEETS ORGANIZATIONAL REALITY: COMPARING INVESTMENT PRACTICES AND PERFORMANCE OF CORPORATE AND INDEPENDENT VENTURE CAPITALISTS [J].

Dushnitsky, Gary ;

Shapira, Zur .

STRATEGIC MANAGEMENT JOURNAL, 2010, 31 (09) :990-1017

[6]

Ernst & Young, 2011, BORD GLOB REP 2011

[7]

Gompers PaulA., 2002, Federal Reserve Bank of Atlanta Economic Review, V87, P1

[8]

Henderson J., 2009, International Journal of Technoentrepreneurship, V2, P29, DOI [10.1504/IJTE.2009.027544, DOI 10.1504/IJTE.2009.027544]

[9] Biotech's wellspring: a survey of the health of the private sector [J].

Huggett, Brady .

NATURE BIOTECHNOLOGY, 2012, 30 (05) :395-400

[10] The problems with today's pharmaceutical business-an outsider's view [J].

Kessel, Mark .

NATURE BIOTECHNOLOGY, 2011, 29 (01) :27-33

← 1 2 →